RUBELLI BEAUTY FACE PREMIUM is a Topical Patch in the Human Otc Drug category. It is labeled and distributed by Rubelli Co.,ltd. The primary component is Adenosine.
| Product ID | 71006-090_492ea283-ca69-4501-8c3b-09607628b97d |
| NDC | 71006-090 |
| Product Type | Human Otc Drug |
| Proprietary Name | RUBELLI BEAUTY FACE PREMIUM |
| Generic Name | Adenosine |
| Dosage Form | Patch |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-03-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | RUBELLI CO.,LTD |
| Substance Name | ADENOSINE |
| Active Ingredient Strength | 0 g/20mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-03-01 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-03-01 |
| Ingredient | Strength |
|---|---|
| ADENOSINE | .008 g/20mL |
| SPL SET ID: | 07090918-7b2a-4c4d-9424-474a7a0544fb |
| Manufacturer | |
| UNII | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 71006-090 | RUBELLI BEAUTY FACE PREMIUM | RUBELLI BEAUTY FACE PREMIUM |
| 0469-8234 | Adenocard | adenosine |
| 0404-9809 | Adenosine | Adenosine |
| 0409-1932 | Adenosine | ADENOSINE |
| 0641-6113 | Adenosine | Adenosine |
| 0703-8776 | Adenosine | Adenosine |
| 0703-8777 | Adenosine | Adenosine |
| 10019-063 | Adenosine | ADENOSINE |
| 16714-180 | Adenosine | Adenosine |
| 16714-556 | Adenosine | Adenosine |
| 16714-972 | Adenosine | Adenosine |
| 16714-997 | Adenosine | Adenosine |
| 17478-542 | Adenosine | Adenosine |
| 17478-544 | Adenosine | Adenosine |
| 17478-953 | Adenosine | Adenosine |
| 23155-258 | Adenosine | Adenosine |
| 23155-259 | Adenosine | Adenosine |
| 25021-301 | adenosine | adenosine |
| 42491-1200 | Tissen ICM 10 | Adenosine |
| 42491-1100 | Tissen NF 10 | Adenosine |